Theodore Alan Huizenga is SVP, Chief Accounting Officer of Ultragenyx Pharmaceutical Inc.. Currently has a direct ownership of 42,251 shares of RARE, which is worth approximately $2.48 Million. The most recent transaction as insider was on May 06, 2021, when has been sold 142 shares (Common Stock) at a price of $113.67 per share, resulting in proceeds of $16,141. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 42.3K
2.14% 3M change
78.92% 12M change
Total Value Held $2.48 Million

Theodore Alan Huizenga Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 06 2021
SELL
Open market or private sale
$16,141 $113.67 p/Share
142 Reduced 0.94%
15,031 Common Stock
Apr 16 2021
BUY
Grant, award, or other acquisition
-
1,500 Added 9.07%
15,044 Common Stock
Mar 08 2021
SELL
Open market or private sale
$362,070 $120.69 p/Share
3,000 Reduced 18.13%
13,544 Common Stock
Mar 01 2021
SELL
Open market or private sale
$101,140 $138.17 p/Share
732 Reduced 4.24%
16,544 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
1,560 Added 8.28%
17,276 Common Stock
Jan 07 2021
SELL
Open market or private sale
$562,600 $140.65 p/Share
4,000 Reduced 20.29%
15,716 Common Stock
Jan 07 2021
BUY
Exercise of conversion of derivative security
$84,000 $21.0 p/Share
4,000 Added 16.37%
20,436 Common Stock
Oct 14 2020
SELL
Open market or private sale
$12,845 $87.98 p/Share
146 Reduced 0.88%
16,436 Common Stock
TAH

Theodore Alan Huizenga

SVP, Chief Accounting Officer
Novato, CA

Track Institutional and Insider Activities on RARE

Follow Ultragenyx Pharmaceutical Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RARE shares.

Notify only if

Insider Trading

Get notified when an Ultragenyx Pharmaceutical Inc. insider buys or sells RARE shares.

Notify only if

News

Receive news related to Ultragenyx Pharmaceutical Inc.

Track Activities on RARE